Företagsekonomiska institutionen


DRIVE AB stands for "Driving reinvestment in R&D for antibiotics and advocating their responsible use" and is a large project that reflects our ambition to connect to societal phenomena.

This EU-funded program deals with antimicrobial resistance, which is a current global threat. Researchers from our International Business group study mechanisms of incentives for international research and development activities that may lead to the commercialisation of new antibiotics. The project is multidisciplinary and includes a large international consortium of academics, business and public partners.